CHEBI ONTOLOGY - ANNOTATIONS
The Chemical Entities of Biological Interest (ChEBI) ontology is downloaded weekly from EMBL-EBI at http://www.ebi.ac.uk/chebi/ . The data is made available under the Creative Commons License (CC BY 3.0, http://creativecommons.org/licenses/by/3.0/ ). For more information see: Degtyarenko et al. (2008) ChEBI: a database and ontology for chemical entities of biological interest. Nucleic Acids Res. 36, D344–D350.
Term: astemizole
Accession: CHEBI:2896
browse the term
Definition: A piperidine compound having a 2-(4-methoxyphenyl)ethyl group at the 1-position and an N-[(4-fluorobenzyl)benzimidazol-2-yl]amino group at the 4-position.
Synonyms: exact_synonym: 1-(4-fluorobenzyl)-N-{1-[2-(4-methoxyphenyl)ethyl]piperidin-4-yl}-1H-benzimidazol-2-amine
related_synonym: 1-(p-Fluorobenzyl)-2-((1-(2-(p-methoxyphenyl)ethyl)piperid-4-yl)amino)benzimidazole; 1-(p-Fluorobenzyl)-2-((1-(p-methoxyphenethyl)-4-piperidyl)amino)benzimidazole; Astemison; Formula=C28H31FN4O; InChI=1S/C28H31FN4O/c1-34-25-12-8-21(9-13-25)14-17-32-18-15-24(16-19-32)30-28-31-26-4-2-3-5-27(26)33(28)20-22-6-10-23(29)11-7-22/h2-13,24H,14-20H2,1H3,(H,30,31); InChIKey=GXDALQBWZGODGZ-UHFFFAOYSA-N; SMILES=COc1ccc(CCN2CCC(CC2)Nc2nc3ccccc3n2Cc2ccc(F)cc2)cc1; astemizol; astemizolum
xref: Beilstein:4830190; CAS:68844-77-9; DrugBank:DB00637; Drug_Central:249; KEGG:C06832; KEGG:D00234; LINCS:LSM-5502
xref_mesh: MESH:D016589
xref: Patent:EP5318; Patent:US4219559
G
Abcb11
ATP-binding cassette, sub-family B member 11
multiple interactions decreases activity
ISO
Astemizole inhibits the reaction [ABCB11 protein results in increased transport of Taurocholic Acid] Astemizole results in decreased activity of ABCB11 protein
CTD
PMID:24014644
NCBI chr 2:69,068,626...69,172,960
Ensembl chr 2:69,068,626...69,172,958
G
Ak3
adenylate kinase 3
increases expression
ISO
Astemizole results in increased expression of AK3 mRNA
CTD
PMID:20221588
NCBI chr19:28,968,715...29,026,122
Ensembl chr19:28,998,233...29,025,361
G
Alas2
aminolevulinic acid synthase 2, erythroid
increases expression
ISO
Astemizole results in increased expression of ALAS2 mRNA
CTD
PMID:20221588
NCBI chr X:149,330,443...149,353,614
Ensembl chr X:149,330,371...149,353,634
G
Angpt2
angiopoietin 2
increases expression
ISO
Astemizole results in increased expression of ANGPT2 mRNA
CTD
PMID:20221588
NCBI chr 8:18,740,279...18,791,578
Ensembl chr 8:18,740,279...18,791,578
G
Atf3
activating transcription factor 3
increases expression
ISO
Astemizole results in increased expression of ATF3 mRNA
CTD
PMID:32661532
NCBI chr 1:190,902,493...190,915,530
Ensembl chr 1:190,902,493...190,950,236
G
Atp1b1
ATPase, Na+/K+ transporting, beta 1 polypeptide
increases expression
ISO
Astemizole results in increased expression of ATP1B1 mRNA
CTD
PMID:20221588
NCBI chr 1:164,264,668...164,285,924
Ensembl chr 1:164,264,678...164,285,924
G
Atp1b2
ATPase, Na+/K+ transporting, beta 2 polypeptide
decreases expression
ISO
Astemizole results in decreased expression of ATP1B2 mRNA
CTD
PMID:20221588
NCBI chr11:69,490,554...69,496,786
Ensembl chr11:69,490,562...69,496,768
G
Atp5f1e
ATP synthase F1 subunit epsilon
increases expression
ISO
Astemizole results in increased expression of ATP5F1E mRNA
CTD
PMID:20221588
NCBI chr 2:174,302,868...174,305,894
Ensembl chr 2:174,302,865...174,305,898
G
Bcl2
B cell leukemia/lymphoma 2
decreases expression
ISO
Astemizole results in decreased expression of BCL2 mRNA
CTD
PMID:20221588
NCBI chr 1:106,465,906...106,642,020
Ensembl chr 1:106,465,908...106,642,004
G
Bmp1
bone morphogenetic protein 1
decreases expression
ISO
Astemizole results in decreased expression of BMP1 mRNA
CTD
PMID:20221588
NCBI chr14:70,711,998...70,758,280
Ensembl chr14:70,711,998...70,757,674
G
Camk2d
calcium/calmodulin-dependent protein kinase II, delta
decreases expression
ISO
Astemizole results in decreased expression of CAMK2D mRNA
CTD
PMID:20221588
NCBI chr 3:126,389,136...126,639,975
Ensembl chr 3:126,389,951...126,639,975
G
Cat
catalase
increases expression
ISO
Astemizole results in increased expression of CAT mRNA
CTD
PMID:20221588
NCBI chr 2:103,284,249...103,315,498
Ensembl chr 2:103,284,194...103,315,505
G
Ccl7
C-C motif chemokine ligand 7
decreases expression
ISO
Astemizole results in decreased expression of CCL7 mRNA
CTD
PMID:20221588
NCBI chr11:81,936,538...81,938,351
Ensembl chr11:81,936,538...81,938,351
G
Cebpb
CCAAT/enhancer binding protein beta
increases expression
ISO
Astemizole results in increased expression of CEBPB mRNA
CTD
PMID:20221588
NCBI chr 2:167,530,835...167,532,352
Ensembl chr 2:167,530,835...167,532,338
G
Cebpg
CCAAT/enhancer binding protein gamma
decreases expression
ISO
Astemizole results in decreased expression of CEBPG mRNA
CTD
PMID:20221588
NCBI chr 7:34,745,847...34,755,991
Ensembl chr 7:34,745,847...34,755,998
G
Cfh
complement component factor h
decreases expression
ISO
Astemizole results in decreased expression of CFH mRNA
CTD
PMID:20221588
NCBI chr 1:140,013,593...140,111,149
Ensembl chr 1:140,012,446...140,111,502
G
Colec12
collectin sub-family member 12
decreases expression
ISO
Astemizole results in decreased expression of COLEC12 mRNA
CTD
PMID:20221588
NCBI chr18:9,707,648...9,877,995
Ensembl chr18:9,707,595...9,882,644
G
Crh
corticotropin releasing hormone
multiple interactions
ISO
Astemizole inhibits the reaction [Corticosterone inhibits the reaction [CRH protein results in increased secretion of Adrenocorticotropic Hormone]]
CTD
PMID:18835572
NCBI chr 3:19,747,565...19,749,560
Ensembl chr 3:19,747,565...19,749,560
G
Cxcl3
C-X-C motif chemokine ligand 3
decreases expression
ISO
Astemizole results in decreased expression of CXCL3 mRNA
CTD
PMID:20221588
NCBI chr 5:90,933,960...90,935,952
Ensembl chr 5:90,933,962...90,937,459
G
Cxcl9
C-X-C motif chemokine ligand 9
decreases expression
ISO
Astemizole results in decreased expression of CXCL9 mRNA
CTD
PMID:20221588
NCBI chr 5:92,469,190...92,475,938
Ensembl chr 5:92,469,206...92,475,938
G
Cyp2j9
cytochrome P450, family 2, subfamily j, polypeptide 9
decreases methylation increases metabolic processing multiple interactions
ISO
CYP2J2 protein results in decreased methylation of Astemizole CYP2J2 protein results in increased metabolism of Astemizole Arachidonic Acid inhibits the reaction [CYP2J2 protein results in decreased methylation of Astemizole]; ebastine inhibits the reaction [CYP2J2 protein results in decreased methylation of Astemizole]
CTD
PMID:12386130 PMID:15861034 PMID:17162467
NCBI chr 4:96,456,661...96,480,748
Ensembl chr 4:96,456,666...96,479,815
G
Eaf1
ELL associated factor 1
increases expression
ISO
Astemizole results in increased expression of EAF1 mRNA
CTD
PMID:20221588
NCBI chr14:31,217,036...31,231,815
Ensembl chr14:31,216,356...31,231,815
G
Egln1
egl-9 family hypoxia-inducible factor 1
increases expression
ISO
Astemizole results in increased expression of EGLN1 mRNA
CTD
PMID:20221588
NCBI chr 8:125,635,325...125,676,063
Ensembl chr 8:125,635,326...125,676,063
G
Eif4a1
eukaryotic translation initiation factor 4A1
increases expression
ISO
Astemizole results in increased expression of EIF4A1 mRNA
CTD
PMID:20221588
NCBI chr11:69,557,762...69,563,249
Ensembl chr11:69,557,762...69,563,249
G
Errfi1
ERBB receptor feedback inhibitor 1
decreases expression
ISO
Astemizole results in decreased expression of ERRFI1 mRNA
CTD
PMID:20221588
NCBI chr 4:150,938,253...150,953,346
Ensembl chr 4:150,938,376...150,953,349
G
Etv5
ets variant 5
decreases expression
ISO
Astemizole results in decreased expression of ETV5 mRNA
CTD
PMID:20221588
NCBI chr16:22,200,063...22,258,320
Ensembl chr16:22,200,059...22,258,469
G
Fam124a
family with sequence similarity 124, member A
increases expression
ISO
Astemizole results in increased expression of FAM124A mRNA
CTD
PMID:20221588
NCBI chr14:62,793,186...62,845,935
Ensembl chr14:62,793,186...62,845,935
G
Fcer1a
Fc receptor, IgE, high affinity I, alpha polypeptide
multiple interactions
ISO
Astemizole inhibits the reaction [FCER1A protein results in increased secretion of HEXB protein]
CTD
PMID:9088877
NCBI chr 1:173,048,836...173,054,799
Ensembl chr 1:173,048,851...173,054,781
G
Gdf10
growth differentiation factor 10
increases expression
ISO
Astemizole results in increased expression of GDF10 mRNA
CTD
PMID:20221588
NCBI chr14:33,645,544...33,658,471
Ensembl chr14:33,645,544...33,659,940
G
Gimap1
GTPase, IMAP family member 1
increases expression
ISO
Astemizole results in increased expression of GIMAP1 mRNA
CTD
PMID:20221588
NCBI chr 6:48,715,981...48,720,729
Ensembl chr 6:48,715,988...48,720,729
G
Gpm6b
glycoprotein m6b
increases expression
ISO
Astemizole results in increased expression of GPM6B mRNA
CTD
PMID:20221588
NCBI chr X:165,021,911...165,172,028
Ensembl chr X:165,021,907...165,171,984
G
Gpx4
glutathione peroxidase 4
increases expression
ISO
Astemizole results in increased expression of GPX4 mRNA
CTD
PMID:20221588
NCBI chr10:79,883,000...79,892,273
Ensembl chr10:79,883,000...79,892,273
G
Hexb
hexosaminidase B
increases secretion multiple interactions
ISO
Astemizole results in increased secretion of HEXB protein Astemizole inhibits the reaction [FCER1A protein results in increased secretion of HEXB protein]
CTD
PMID:9088877
NCBI chr13:97,312,839...97,334,865
Ensembl chr13:97,312,839...97,334,865
G
Hmox1
heme oxygenase 1
increases expression
ISO
Astemizole results in increased expression of HMOX1 mRNA
CTD
PMID:32661532
NCBI chr 8:75,820,246...75,827,221
Ensembl chr 8:75,820,249...75,827,217
G
Hrh1
histamine receptor H1
multiple interactions
EXP ISO
[Astemizole binds to and results in decreased activity of HRH1 protein] which affects the susceptibility to Aminophylline Astemizole inhibits the reaction [Histamine results in decreased activity of [KCNQ2 protein co-treated with KCNQ3 protein co-treated with HRH1 protein]]
CTD
PMID:12147327 PMID:16129921
NCBI chr 6:114,374,897...114,459,432
Ensembl chr 6:114,374,897...114,460,257
G
Hsp90ab1
heat shock protein 90 alpha (cytosolic), class B member 1
decreases expression
ISO
Astemizole results in decreased expression of HSP90AB1 mRNA
CTD
PMID:20221588
NCBI chr17:45,878,704...45,884,187
Ensembl chr17:45,878,701...45,884,197
G
Hspa8
heat shock protein 8
increases expression
ISO
Astemizole results in increased expression of HSPA8 mRNA
CTD
PMID:20221588
NCBI chr 9:40,712,572...40,716,498
Ensembl chr 9:40,712,280...40,721,383
G
Hspb8
heat shock protein 8
increases expression
ISO
Astemizole results in increased expression of HSPB8 mRNA
CTD
PMID:20221588
NCBI chr 5:116,546,550...116,560,923
Ensembl chr 5:116,546,550...116,560,923
G
Hsph1
heat shock 105kDa/110kDa protein 1
decreases expression
ISO
Astemizole results in decreased expression of HSPH1 mRNA
CTD
PMID:20221588
NCBI chr 5:149,540,308...149,562,594
Ensembl chr 5:149,537,752...149,559,841
G
Icam1
intercellular adhesion molecule 1
multiple interactions
ISO
Astemizole inhibits the reaction [IL1B protein results in increased expression of ICAM1 protein]
CTD
PMID:17517105
NCBI chr 9:20,927,236...20,940,110
Ensembl chr 9:20,927,281...20,940,113
G
Ifit3
interferon-induced protein with tetratricopeptide repeats 3
decreases expression
ISO
Astemizole results in decreased expression of IFIT3 mRNA
CTD
PMID:20221588
NCBI chr19:34,560,519...34,566,382
Ensembl chr19:34,560,931...34,566,131
G
Igf1
insulin-like growth factor 1
multiple interactions
ISO
Astemizole inhibits the reaction [IGF1 protein results in increased activity of KCNH1 protein]
CTD
PMID:17520698
NCBI chr10:87,694,127...87,772,909
Ensembl chr10:87,694,127...87,772,904
G
Igsf6
immunoglobulin superfamily, member 6
decreases expression
ISO
Astemizole results in decreased expression of IGSF6 mRNA
CTD
PMID:20221588
NCBI chr 7:120,663,290...120,673,753
Ensembl chr 7:120,663,290...120,673,795
G
Il1b
interleukin 1 beta
multiple interactions
ISO
Astemizole inhibits the reaction [IL1B protein results in increased expression of ICAM1 protein]; Astemizole inhibits the reaction [IL1B protein results in increased expression of VCAM1 protein]
CTD
PMID:17517105
NCBI chr 2:129,206,490...129,213,059
Ensembl chr 2:129,206,490...129,213,059
G
Il36rn
interleukin 36 receptor antagonist
increases expression
ISO
Astemizole results in increased expression of IL36RN mRNA
CTD
PMID:20221588
NCBI chr 2:24,166,966...24,172,444
Ensembl chr 2:24,166,966...24,173,438
G
Il7r
interleukin 7 receptor
decreases expression
ISO
Astemizole results in decreased expression of IL7R mRNA
CTD
PMID:20221588
NCBI chr15:9,505,880...9,530,270
Ensembl chr15:9,505,874...9,530,262
G
Itga8
integrin alpha 8
increases expression
ISO
Astemizole results in increased expression of ITGA8 mRNA
CTD
PMID:20221588
NCBI chr 2:12,111,443...12,306,755
Ensembl chr 2:12,111,443...12,306,733
G
Kcnh1
potassium voltage-gated channel, subfamily H (eag-related), member 1
multiple interactions affects binding decreases activity
ISO
Astemizole binds to and results in decreased activity of KCNH1 protein; Astemizole inhibits the reaction [IGF1 protein results in increased activity of KCNH1 protein] Astemizole binds to KCNH1 protein Astemizole results in decreased activity of KCNH1 protein
CTD
PMID:14985237 PMID:16816845 PMID:17520698 PMID:18471075 PMID:18497958 PMID:20050851 PMID:32533968 More...
NCBI chr 1:191,871,759...192,192,467
Ensembl chr 1:191,873,082...192,192,467
G
Kcnh2
potassium voltage-gated channel, subfamily H (eag-related), member 2
multiple interactions decreases activity affects localization affects binding
ISO EXP
Astemizole binds to and results in decreased activity of KCNH2 protein; Astemizole inhibits the reaction [arsenic trioxide results in increased degradation of KCNH2 protein]; Astemizole inhibits the reaction [Digoxin results in decreased activity of KCNH2 protein]; Astemizole inhibits the reaction [Digoxin results in decreased metabolism of KCNH2 protein modified form]; Astemizole inhibits the reaction [KCNH2 protein results in increased transport of Thallium]; dofetilide analog inhibits the reaction [Astemizole binds to KCNH2 protein]; Hydrogen Peroxide inhibits the reaction [Astemizole results in decreased activity of KCNH2 protein mutant form]; Potassium promotes the reaction [Astemizole binds to KCNH2 protein] Astemizole affects the localization of KCNH2 protein mutant form Astemizole binds to KCNH2 gene polymorphism; Astemizole binds to KCNH2 protein
CTD
PMID:8641472 PMID:9658196 PMID:10376921 PMID:10422790 PMID:10531299 PMID:10828461 PMID:11040061 PMID:11082114 PMID:11705456 PMID:11741928 PMID:12388285 PMID:15272206 PMID:15671647 PMID:15740727 PMID:16723379 PMID:18701618 PMID:19139152 PMID:19583963 PMID:21158687 PMID:24052561 PMID:24200993 PMID:28521025 More...
NCBI chr 5:24,524,583...24,556,671
Ensembl chr 5:24,524,587...24,556,602
G
Kcnq2
potassium voltage-gated channel, subfamily Q, member 2
multiple interactions
ISO
Astemizole inhibits the reaction [Histamine results in decreased activity of [KCNQ2 protein co-treated with KCNQ3 protein co-treated with HRH1 protein]]
CTD
PMID:12147327
NCBI chr 2:180,717,372...180,777,368
Ensembl chr 2:180,717,372...180,777,093
G
Kcnq3
potassium voltage-gated channel, subfamily Q, member 3
multiple interactions
ISO
Astemizole inhibits the reaction [Histamine results in decreased activity of [KCNQ2 protein co-treated with KCNQ3 protein co-treated with HRH1 protein]]
CTD
PMID:12147327
NCBI chr15:65,858,223...66,158,485
Ensembl chr15:65,858,236...66,158,491
G
Maoa
monoamine oxidase A
decreases expression
ISO
Astemizole results in decreased expression of MAOA mRNA
CTD
PMID:20221588
NCBI chr X:16,485,937...16,554,051
Ensembl chr X:16,485,937...16,554,057
G
Mapt
microtubule-associated protein tau
affects binding
ISO
Astemizole binds to MAPT protein alternative form
CTD
PMID:20110603
NCBI chr11:104,120,235...104,222,916
Ensembl chr11:104,122,216...104,222,916
G
Mmp2
matrix metallopeptidase 2
decreases expression
ISO
Astemizole results in decreased expression of MMP2 mRNA
CTD
PMID:20221588
NCBI chr 8:93,553,920...93,580,049
Ensembl chr 8:93,553,919...93,580,048
G
Ms4a6c
membrane-spanning 4-domains, subfamily A, member 6C
decreases expression
ISO
Astemizole results in decreased expression of MS4A6A mRNA
CTD
PMID:20221588
NCBI chr19:11,446,718...11,464,433
Ensembl chr19:11,446,730...11,459,556
G
Mt2
metallothionein 2
increases expression
ISO
Astemizole results in increased expression of MT2A mRNA
CTD
PMID:32661532
NCBI chr 8:94,899,246...94,900,195
Ensembl chr 8:94,899,292...94,900,196
G
Mtf1
metal response element binding transcription factor 1
multiple interactions
ISO
MTF1 protein affects the reaction [Astemizole results in increased expression of MT1M mRNA]
CTD
PMID:32661532
NCBI chr 4:124,696,342...124,743,593
Ensembl chr 4:124,695,897...124,743,593
G
Mtus1
mitochondrial tumor suppressor 1
decreases expression
ISO
Astemizole results in decreased expression of MTUS1 mRNA
CTD
PMID:20221588
NCBI chr 8:41,443,949...41,587,318
Ensembl chr 8:41,443,951...41,586,763
G
Myh6
myosin, heavy polypeptide 6, cardiac muscle, alpha
increases expression
ISO
Astemizole results in increased expression of MYH6 mRNA
CTD
PMID:20221588
NCBI chr14:55,179,378...55,205,553
Ensembl chr14:55,179,378...55,204,384
G
Ndufs7
NADH:ubiquinone oxidoreductase core subunit S7
increases expression
ISO
Astemizole results in increased expression of NDUFS7 mRNA
CTD
PMID:20221588
NCBI chr10:80,084,939...80,092,628
Ensembl chr10:80,084,955...80,092,628
G
Ndufv2
NADH:ubiquinone oxidoreductase core subunit V2
increases expression
ISO
Astemizole results in increased expression of NDUFV2 mRNA
CTD
PMID:20221588
NCBI chr17:66,385,790...66,408,554
Ensembl chr17:66,385,633...66,408,554
G
Necab1
N-terminal EF-hand calcium binding protein 1
decreases expression
ISO
Astemizole results in decreased expression of NECAB1 mRNA
CTD
PMID:20221588
NCBI chr 4:14,952,245...15,149,804
Ensembl chr 4:14,952,245...15,149,794
G
Nr4a3
nuclear receptor subfamily 4, group A, member 3
increases expression
ISO
Astemizole results in increased expression of NR4A3 mRNA
CTD
PMID:20221588
NCBI chr 4:48,045,098...48,086,446
Ensembl chr 4:48,045,153...48,086,447
G
Oasl1
2'-5' oligoadenylate synthetase-like 1
decreases expression
ISO
Astemizole results in decreased expression of OASL1 mRNA
CTD
PMID:20221588
NCBI chr 5:115,061,236...115,075,970
Ensembl chr 5:115,061,299...115,075,974
G
Osbpl3
oxysterol binding protein-like 3
increases expression
ISO
Astemizole results in increased expression of OSBPL3 mRNA
CTD
PMID:20221588
NCBI chr 6:50,270,307...50,433,334
Ensembl chr 6:50,270,310...50,433,181
G
Osgepl1
O-sialoglycoprotein endopeptidase-like 1
increases expression
ISO
Astemizole results in increased expression of OSGEPL1 mRNA
CTD
PMID:20221588
NCBI chr 1:53,352,070...53,365,502
Ensembl chr 1:53,352,783...53,365,502
G
Park7
Parkinson disease (autosomal recessive, early onset) 7
increases expression
ISO
Astemizole results in increased expression of PARK7 mRNA
CTD
PMID:20221588
NCBI chr 4:150,981,590...150,994,378
Ensembl chr 4:150,981,590...150,998,894
G
Pcdh17
protocadherin 17
decreases expression
ISO
Astemizole results in decreased expression of PCDH17 mRNA
CTD
PMID:20221588
NCBI chr14:84,680,626...84,775,005
Ensembl chr14:84,681,003...84,776,442
G
Peli2
pellino 2
increases expression
ISO
Astemizole results in increased expression of PELI2 mRNA
CTD
PMID:20221588
NCBI chr14:48,358,096...48,519,035
Ensembl chr14:48,358,280...48,519,032
G
Psmb5
proteasome (prosome, macropain) subunit, beta type 5
increases expression
ISO
Astemizole results in increased expression of PSMB5 mRNA
CTD
PMID:20221588
NCBI chr14:54,851,577...54,855,452
Ensembl chr14:54,851,576...54,855,479
G
Ptgs1
prostaglandin-endoperoxide synthase 1
decreases expression
ISO
Astemizole results in decreased expression of PTGS1 mRNA
CTD
PMID:20221588
NCBI chr 2:36,106,758...36,142,287
Ensembl chr 2:36,120,438...36,142,284
G
Pycr3
pyrroline-5-carboxylate reductase 3
increases expression
ISO
Astemizole results in increased expression of PYCR3 mRNA
CTD
PMID:20221588
NCBI chr15:75,788,319...75,793,369
Ensembl chr15:75,788,326...75,793,409
G
Pygm
muscle glycogen phosphorylase
increases expression
ISO
Astemizole results in increased expression of PYGM mRNA
CTD
PMID:20221588
NCBI chr19:6,434,438...6,448,494
Ensembl chr19:6,434,429...6,448,489
G
S100a8
S100 calcium binding protein A8 (calgranulin A)
increases expression
ISO
Astemizole results in increased expression of S100A8 mRNA
CTD
PMID:20221588
NCBI chr 3:90,576,378...90,577,341
Ensembl chr 3:90,576,285...90,577,342
G
S100b
S100 protein, beta polypeptide, neural
decreases expression
ISO
Astemizole results in decreased expression of S100B mRNA
CTD
PMID:20221588
NCBI chr10:76,089,670...76,097,153
Ensembl chr10:76,089,687...76,096,993
G
Sik1
salt inducible kinase 1
decreases expression
ISO
Astemizole results in decreased expression of SIK1 mRNA
CTD
PMID:20221588
NCBI chr17:32,063,222...32,074,808
Ensembl chr17:32,063,224...32,074,778
G
Slc1a1
solute carrier family 1 (neuronal/epithelial high affinity glutamate transporter, system Xag), member 1
increases expression
ISO
Astemizole results in increased expression of SLC1A1 mRNA
CTD
PMID:20221588
NCBI chr19:28,812,535...28,891,360
Ensembl chr19:28,812,449...28,891,360
G
Sod2
superoxide dismutase 2, mitochondrial
increases expression
ISO
Astemizole results in increased expression of SOD2 mRNA
CTD
PMID:20221588
NCBI chr17:13,226,726...13,237,006
Ensembl chr17:13,225,733...13,258,950
G
Sqstm1
sequestosome 1
increases expression
ISO
Astemizole results in increased expression of SQSTM1 mRNA
CTD
PMID:20221588
NCBI chr11:50,090,979...50,105,303
Ensembl chr11:50,090,193...50,101,654
G
Tgfb2
transforming growth factor, beta 2
increases expression
ISO
Astemizole results in increased expression of TGFB2 mRNA
CTD
PMID:20221588
NCBI chr 1:186,354,984...186,441,504
Ensembl chr 1:186,354,989...186,438,186
G
Tlr2
toll-like receptor 2
decreases expression
ISO
Astemizole results in decreased expression of TLR2 mRNA
CTD
PMID:20221588
NCBI chr 3:83,743,579...83,749,045
Ensembl chr 3:83,743,579...83,749,074
G
Tlr7
toll-like receptor 7
decreases expression
ISO
Astemizole results in decreased expression of TLR7 mRNA
CTD
PMID:20221588
NCBI chr X:166,086,376...166,113,570
Ensembl chr X:166,087,925...166,113,554
G
Tmod1
tropomodulin 1
increases expression
ISO
Astemizole results in increased expression of TMOD1 mRNA
CTD
PMID:20221588
NCBI chr 4:46,038,940...46,116,032
Ensembl chr 4:46,038,935...46,116,032
G
Trf
transferrin
decreases expression
ISO
Astemizole results in decreased expression of TF mRNA
CTD
PMID:20221588
NCBI chr 9:103,086,075...103,107,485
Ensembl chr 9:103,081,200...103,107,643
G
Vcam1
vascular cell adhesion molecule 1
multiple interactions
ISO
Astemizole inhibits the reaction [IL1B protein results in increased expression of VCAM1 protein]
CTD
PMID:17517105
NCBI chr 3:115,903,669...115,923,337
Ensembl chr 3:115,903,598...115,923,337
G
Vcan
versican
decreases expression
ISO
Astemizole results in decreased expression of VCAN mRNA
CTD
PMID:20221588
NCBI chr13:89,803,429...89,891,146
Ensembl chr13:89,803,431...89,890,628
Term paths to the root one shortest all shortest one longest all longest one shortest and longest all